These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3362383)

  • 1. Malignant hyperthermia in myotonia congenita.
    Heiman-Patterson T; Martino C; Rosenberg H; Fletcher J; Tahmoush A
    Neurology; 1988 May; 38(5):810-2. PubMed ID: 3362383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to induce malignant hyperthermia in myotonic goats.
    Newberg LA; Lambert EH; Gronert GA
    Br J Anaesth; 1983 Jan; 55(1):57-60. PubMed ID: 6821623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases.
    Flewellen EH; Nelson TE
    Can Anaesth Soc J; 1982 Jan; 29(1):42-9. PubMed ID: 7055743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hyperpyrexia myopathy.
    Harriman DG; Sumner DW; Ellis FR
    Q J Med; 1973 Oct; 42(168):639-64. PubMed ID: 4802524
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant hyperthermia under general anaesthesia. Abnormal histochemical and electron-microscopic muscle findings in combination with pathological serum-CPK-values evidencing the existence of primary myopathy (author's transl)].
    Bernhardt D; Schiller H
    Anaesthesist; 1973 Aug; 22(8):367-72. PubMed ID: 4270680
    [No Abstract]   [Full Text] [Related]  

  • 8. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?
    Lehmann-Horn F; Iaizzo PA
    Br J Anaesth; 1990 Nov; 65(5):692-7. PubMed ID: 2248848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro muscle contracture investigations on the malignant hyperthermia like episodes in myotonia congenita.
    Hoppe K; Lehmann-Horn F; Chaiklieng S; Jurkat-Rott K; Adolph O; Klingler W
    Acta Anaesthesiol Scand; 2013 Sep; 57(8):1017-23. PubMed ID: 23639175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders.
    Farbu E; Søfteland E; Bindoff LA
    Acta Anaesthesiol Scand; 2003 May; 47(5):630-4. PubMed ID: 12699527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
    Cosgrove SB; Eisele PH; Martucci RW; Gronert GA
    Lab Anim Sci; 1992 Oct; 42(5):482-5. PubMed ID: 1460848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anesthesia in myotonia].
    Lienhart A
    Ann Fr Anesth Reanim; 1989; 8(5):469-84. PubMed ID: 2534024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia and myotonia congenita (Thomsen's disease).
    Haberer JP; Fabre F; Rose E
    Anaesthesia; 1989 Feb; 44(2):166. PubMed ID: 2929948
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular genetic tests are not yet useful for diagnosis of malignant hyperthermia].
    Ranklev-Twetman E; Isander G; Fletcher R
    Lakartidningen; 1992 May; 89(21):1869. PubMed ID: 1598048
    [No Abstract]   [Full Text] [Related]  

  • 15. Masseter muscle rigidity and malignant hyperthermia susceptibility.
    Rosenberg H; Fletcher JE
    Anesth Analg; 1986 Feb; 65(2):161-4. PubMed ID: 3942303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N; Brum JM; Mitsumoto H; DeBoer GE
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Examination of the family of a patient susceptible to anesthetic malignant hyperthermia].
    Krivosic-Horber R; Theunynck D; Krivosic I; Adnet P; Guévart E
    Ann Fr Anesth Reanim; 1986; 5(3):326-9. PubMed ID: 3777561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia susceptibility in neuroleptic malignant syndrome.
    Caroff SN; Rosenberg H; Fletcher JE; Heiman-Patterson TD; Mann SC
    Anesthesiology; 1987 Jul; 67(1):20-5. PubMed ID: 3605730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene.
    Vita GM; Olckers A; Jedlicka AE; George AL; Heiman-Patterson T; Rosenberg H; Fletcher JE; Levitt RC
    Anesthesiology; 1995 May; 82(5):1097-103. PubMed ID: 7741283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Myopathies and malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 Aug; 3(5929):520. PubMed ID: 4414306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.